Clinical characteristics of patients by MYD88 mutational status
| Clinical characteristics . | Overall (n = 14) . | MYD88L265P (n = 10) . | MYD88WT (n = 4) . |
|---|---|---|---|
| Median age, y (range) | 60 (48-70) | 61.5 (48-70) | 58 (53-62) |
| Median serum M-spike, g/dL (range) | 0.9 (0.1-2.4) | 1.15 (0.24-2.4) | 0.55 (0.1-0.9) |
| Cardiac involvement (n) | 3 | 1 | 2 |
| Peripheral or autonomic neuropathy (n) | 4 | 4 | 0 |
| Median OS, mo (95% CI) | 95.8 (41.2-NR) | 83.0 (11.9-108.6) | NR (16.4-NR) |
| Median PFS | 48.2 (27.8-120.3) | 43.3 (11.9-75.7) | 120.3 (14.0-120.3) |
| Clinical characteristics . | Overall (n = 14) . | MYD88L265P (n = 10) . | MYD88WT (n = 4) . |
|---|---|---|---|
| Median age, y (range) | 60 (48-70) | 61.5 (48-70) | 58 (53-62) |
| Median serum M-spike, g/dL (range) | 0.9 (0.1-2.4) | 1.15 (0.24-2.4) | 0.55 (0.1-0.9) |
| Cardiac involvement (n) | 3 | 1 | 2 |
| Peripheral or autonomic neuropathy (n) | 4 | 4 | 0 |
| Median OS, mo (95% CI) | 95.8 (41.2-NR) | 83.0 (11.9-108.6) | NR (16.4-NR) |
| Median PFS | 48.2 (27.8-120.3) | 43.3 (11.9-75.7) | 120.3 (14.0-120.3) |